Literature DB >> 7907547

Thrombo-embolic and vascular complications in vasculitis syndromes.

T Somer1.   

Abstract

The vasculitides are relatively rare diseases characterized by inflammation and necrosis of vessel walls and, hence, often complicated by vascular and thromboembolic manifestations. The causes and pathogenesis of most vasculitides are only partially known. However, in many there are strong implications of both immune-complex and cell-mediated pathogenetic mechanisms. Tissue ischaemia, thrombosis as well as mediators and end-products of vascular endothelial inflammation are thought to cause most of the vasculitic manifestations. Thrombo-embolic and cardiovascular manifestations and complications are most commonly found in the vasculitides with necrotizing vascular inflammation, i.e. Behçet's disease, Buerger's disease, Kawasaki's syndrome, polyarteritis nodosa and vasculitis of rheumatoid arteritis. The granulomatous vasculitides are less frequently complicated by thrombo-embolic manifestations. Vasculitis may also be an iatrogenic complication of a therapeutic intervention, such as an IC-mediated hypersensitivity vasculitis after streptokinase treatment or an anti-endothelial cell antibody-associated coronary vasculitis after heart transplantation.

Entities:  

Mesh:

Year:  1993        PMID: 7907547

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  2 in total

1.  Intractable coronary fibromuscular dysplasia leading to end-stage heart failure and fatal heart transplantation.

Authors:  Magdalena Maria Cattaneo; Marco Moccetti; Mattia Cattaneo; Daniel Sürder; Thomas Suter; Michele Martinelli; Eva Roost; Jürg Schmidli; Yara Banz; Carmen Schneiders; Giovanni Pedrazzini; Roberto Corti; Lorenz Räber; Filippo Crea; Paul Mohacsi; Augusto Gallino
Journal:  ESC Heart Fail       Date:  2020-01-29

2.  Vascular thromboses with retroperitoneal fibrosis: a case report.

Authors:  Hanane Charaf; Rachida Zahraoui; Mouna Soualhi; Nezha Rguig; Jamal Eddine Bourkadi; Daoud Ali Mohamed; Nasser Ittimad
Journal:  J Med Case Rep       Date:  2022-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.